Nature Biomedical Engineering, Published online: 05 August 2026; doi:10.1038/s41551-026-01765-w Engineered lipid nanoparticles enable CD34-targeted delivery and in vivo editing of haematopoietic stem and progenitor cells while preserving haematopoiesis.